Branch Teams Up With Facebook to Improve Ad Campaign Effectiveness
Measuring ad campaign performance in the digital ecosystem is a tall task. That's why Branch, a company that helps brands optimize their mobile experience, is launching a new tool called 'Universal Ads' and is teaming up with Facebook in a Mobile Measurement Partnership. Eric Stein, Chief Revenue Officer at Branch, joined us to explain how this will help brands measure the true impact of mobile advertising.
Stein explained the incentive for Facebook to team up with Branch. He said Facebook needs third parties to measure the impact of campaigns because Facebook "can't grade its own homework." Branch wants to be looked at as an objective source of information.
Campaign effectiveness is difficult to measure. Brands are spending millions of dollars on campaigns. Due to the many platforms that campaigns run on, it is even harder to gain insights. Stein shares how Branch makes it easier for brands to get a grip on the success of their marketing efforts.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
